YOUR CONDITION, EXPLAINED
Malignant Neoplasms of the Digestive System VA Disability Rating
The VA rates Malignant Neoplasms of the Digestive System under diagnostic code 7343, in 38 CFR § 4.114 (digestive system), and the schedule provides a single evaluation under it: 100%.
Free · No account needed
Save your Malignant Neoplasms of the Digestive System guide
Email yourself this Malignant Neoplasms of the Digestive System guide so the rating criteria, evidence checklist, and preparation tips are easy to find later.
A CLEARER PATH FORWARD
Make sense of your next step.
01Understand the rating02Know what to gather03Plan your preparationTHE ESSENTIALS
How the VA rates Malignant Neoplasms of the Digestive System
DC 7343 is the digestive system's cancer code, and it has one rating: 100 percent. The whole of its criteria is its own title — malignant neoplasms of the digestive system, exclusive of skin growths — so nothing about stage, site or treatment changes the percentage while it runs. What the code does carry is a note about when it stops: the 100 percent continues beyond the cessation of any surgical, X-ray, antineoplastic chemotherapy or other therapeutic procedure, and six months after that treatment is discontinued a mandatory VA examination determines the rating from then on.
DC 7343 states one criterion and one evaluation: malignant neoplasms of the digestive system, exclusive of skin growths — 100 percent. There is no second tier, no severity scale and no distinction by organ; the code covers the digestive system's malignancies as a class, and skin growths are the one exclusion it names. Its note is the part that decides how long the evaluation lasts. A rating of 100 percent shall continue beyond the cessation of any surgical, X-ray, antineoplastic chemotherapy or other therapeutic procedure. Six months after discontinuance of such treatment, the appropriate disability rating shall be determined by mandatory VA examination, and any change in evaluation based upon that or any subsequent examination is subject to 38 CFR 3.105(e), the provision that governs a reduction. So the 100 percent does not end when treatment ends, and it does not end on a schedule: it ends on an examination, and a reduction that follows has its own procedure. Two things the code does NOT say are worth stating plainly, because the schedule is silent rather than permissive. It does not name the code that rates the residuals after the mandatory examination — that is what the examination is for, and the residual is rated under whichever digestive code fits what is left. And DC 7343 is outside 38 CFR 4.114's single-evaluation rule: that paragraph covers diagnostic codes 7301 through 7329, 7331, 7342, 7345 through 7350, 7352, and 7355 through 7357, which does not include this code. 38 CFR 4.31 supplies a 0 percent under any code where the requirements for a compensable evaluation are not met, which is the only other percentage this code can produce.
- Diagnostic code
- 7343
- Rating schedule
- 38 CFR § 4.114
- Schedule levels
- 100%
How does the VA choose a rating level?
There is no higher or lower step inside this code: a rating decision either finds its criteria met or it does not. Where they are not met, 38 CFR § 4.31 assigns a 0% evaluation: service connection granted, at a level that does not pay.
EXPLORE THE PERCENTAGES
Malignant Neoplasms of the Digestive System VA rating criteria (DC 7343)
This condition has one published rating level. Read the criteria, then explore the details and monthly pay.
These are published rating criteria. Selecting a level does not predict your VA decision.
IN THE REGULATION’S OWN WORDS
What 38 CFR also says about Malignant Neoplasms of the Digestive System
The notes 38 CFR Part 4 prints with these criteria, quoted. They govern how the evaluation is made without being a rating level themselves.
- “Note: A rating of 100 percent shall continue beyond the cessation of any surgical, X-ray, antineoplastic chemotherapy or other therapeutic procedure. Six months after discontinuance of such treatment, the appropriate disability rating shall be determined by mandatory VA examination. Any change in evaluation based upon that or any subsequent examination shall be subject to the provisions of § 3.105(e) of this chapter. If there has been no local recurrence or metastasis, rate on residuals.”DC 7343
BUILD YOUR EVIDENCE, ONE PIECE AT A TIME
Evidence for your Malignant Neoplasms of the Digestive System claim
A long list feels easier when you have a place to start. Use this checklist to see what you have and what still needs gathering.
Check off what you’ve gathered. Progress stays on this page until you leave or refresh.
THE EXAM FORM
Which DBQ is used for Malignant Neoplasms of the Digestive System?
VA publishes its questionnaires by body system; find the one for this condition on VA's list.
Source: VA: Public Disability Benefits Questionnaires (DBQs), read September 18, 2026.
SMALL DETAILS. BETTER PREPARATION.
Preparing your Malignant Neoplasms of the Digestive System claim
Start with the practical tips, then explore the common oversights. You don’t need to work through everything at once.
Practical tips for your claim4 tips
- 01
Put the treatment end date in the claim in writing. The six-month clock in DC 7343's note runs from the discontinuance of treatment, and that single date decides when the mandatory examination is due.
- 02
Build the residuals file while the 100 percent is running. The examination at six months determines the appropriate disability rating from that point, and it can only rate what is documented.
- 03
Read any proposed reduction against 38 CFR 3.105(e), which the note names by number as the provision governing a change in evaluation following the mandatory examination or any subsequent one.
- 04
Do not assume 38 CFR 4.114's single-evaluation rule applies here. It covers DCs 7301-7329, 7331, 7342, 7345-7350, 7352 and 7355-7357, and DC 7343 is not among them.
C&P exam pitfalls to keep in mind3 tips
- 01
A six-month examination scheduled from the wrong date. The note runs six months from the DISCONTINUANCE of surgical, X-ray, antineoplastic chemotherapy or other therapeutic treatment, not from diagnosis and not from the last appointment of any kind.
- 02
An examination that records remission and stops there. The purpose of the mandatory examination is to determine the appropriate disability rating from that point, which means the residuals have to be examined and described, not just the absence of active disease.
- 03
Ongoing therapy left out of the record. Treatment that has not been discontinued has not started the clock, and the note keeps the 100 percent running beyond the cessation of any of the procedures it lists.
Common filing mistakes4 tips
- 01
Arguing severity. DC 7343 has one evaluation and one criterion, so there is no tier to reach for while the code applies — stage, site and treatment do not move it.
- 02
Treating the end of treatment as the end of the rating. The note continues the 100 percent beyond the cessation of any surgical, X-ray, antineoplastic chemotherapy or other therapeutic procedure, and replaces it only after a mandatory examination six months after discontinuance.
- 03
Letting a reduction pass unanswered. A change in evaluation based on that examination or any subsequent one is subject to 38 CFR 3.105(e), which has its own notice and response procedure.
- 04
Filing nothing for the residuals. The mandatory examination determines the rating from then on, and what it has to work with is the record of what the disease and its treatment left behind.
When symptoms may first appear2 tips
- 01
The schedule describes no onset for this code. DC 7343 turns on the presence of a malignant neoplasm of the digestive system, and its only timing rule runs the other way — forward from the end of treatment rather than back from a first symptom.
- 02
The one interval the regulation fixes is six months: the note makes a VA examination mandatory six months after any surgical, X-ray, antineoplastic chemotherapy or other therapeutic procedure is discontinued, and the rating from that point is determined by that examination.
YOUR SERVICE STORY
Military jobs associated with Malignant Neoplasms of the Digestive System
More by branch: Army · Marines · Navy · Coast Guard
LET’S CLEAR A FEW THINGS UP
Common questions about Malignant Neoplasms of the Digestive System
Is Malignant Neoplasms of the Digestive System a VA-rated disability?
Yes. The VA rates Malignant Neoplasms of the Digestive System under VASRD diagnostic code 7343 (Digestive System). DC 7343 is the digestive system's cancer code, and it has one rating: 100 percent. The whole of its criteria is its own title — malignant neoplasms of the digestive system, exclusive of skin growths — so nothing about stage, site or treatment changes the percentage while it runs. What the code does carry is a note about when it stops: the 100 percent continues beyond the cessation of any surgical, X-ray, antineoplastic chemotherapy or other therapeutic procedure, and six months after that treatment is discontinued a mandatory VA examination determines the rating from then on.
What VA disability rating can I get for Malignant Neoplasms of the Digestive System?
Possible VA ratings for Malignant Neoplasms of the Digestive System are 100%, 0%. The 0% level comes from 38 CFR 4.31, which assigns it wherever no compensable level is met. Examples: 100%: Malignant neoplasms of the digestive system, exclusive of skin growths.
What evidence helps prove Malignant Neoplasms of the Digestive System for VA disability?
Strong evidence for a Malignant Neoplasms of the Digestive System claim includes: A pathology report naming the malignancy and the digestive-system site. DC 7343's single criterion is the presence of a malignant neoplasm of the digestive system, so the diagnosis is the whole of what the 100 percent rests on; Treatment records with dates — surgery, radiation, antineoplastic chemotherapy, or other therapeutic procedure. The note runs the 100 percent beyond the cessation of treatment and starts a six-month clock from discontinuance, so the date treatment stopped is the date that matters; The report of the mandatory VA examination six months after treatment is discontinued, which is what the note makes the basis for the rating from that point; Records of what the treatment left behind — resection, adhesions, weight loss, impaired nutrition, an ostomy — since the residual is what the post-examination evaluation is built from.
What mistakes should veterans avoid when claiming Malignant Neoplasms of the Digestive System?
Common pitfalls when filing for Malignant Neoplasms of the Digestive System: Arguing severity. DC 7343 has one evaluation and one criterion, so there is no tier to reach for while the code applies — stage, site and treatment do not move it; Treating the end of treatment as the end of the rating. The note continues the 100 percent beyond the cessation of any surgical, X-ray, antineoplastic chemotherapy or other therapeutic procedure, and replaces it only after a mandatory examination six months after discontinuance; Letting a reduction pass unanswered. A change in evaluation based on that examination or any subsequent one is subject to 38 CFR 3.105(e), which has its own notice and response procedure; Filing nothing for the residuals. The mandatory examination determines the rating from then on, and what it has to work with is the record of what the disease and its treatment left behind.
When does the 100 percent rating for digestive system cancer end?
Not when treatment ends. DC 7343's note continues the 100 percent beyond the cessation of any surgical, X-ray, antineoplastic chemotherapy or other therapeutic procedure. Six months after that treatment is discontinued, a mandatory VA examination determines the appropriate disability rating from that point, and any change in evaluation based on that examination or any subsequent one is subject to 38 CFR 3.105(e) — the provision that governs how a reduction is proposed and answered. So the two dates that matter are the date treatment was discontinued and the date of the examination six months later.
Does the VA rate stomach, colon and esophageal cancer differently?
Not under this code. DC 7343 reads "malignant neoplasms of the digestive system, exclusive of skin growths" and states a single 100 percent evaluation, with no distinction by organ, stage or treatment. Site becomes relevant afterwards: the mandatory examination six months after treatment is discontinued determines the rating from then on, and the residuals are what that evaluation is built from.
Official sources
- 38 CFR § 4.114, Schedule of ratings, digestive system (Diagnostic Code 7343)
- 38 CFR § 4.31, zero percent evaluations
Criteria in quotation marks are the regulation’s own words; everything else on this page is Vetrify’s summary of it. The eCFR text is authoritative. See how Vetrify derives its numbers.
How these figures are checked: our methodology and the open dataset.
VA Calc: Disability Pay
Combine your ratings & see monthly pay on your iPhone · Works offline